Suppr超能文献

病例报告:通过三阶段根治性同步放化疗实现长期完全缓解的转移性胃鳞状细胞癌

Case report: Metastatic gastric squamous cell carcinoma with long duration of complete response via three-staged radical concurrent chemoradiotherapy.

作者信息

Zang Rui, Zheng Linpeng, Xie Lijiao, Zhong Liangzhi, Sun Jianguo

机构信息

Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China.

出版信息

Heliyon. 2024 Oct 18;10(21):e39266. doi: 10.1016/j.heliyon.2024.e39266. eCollection 2024 Nov 15.

Abstract

INTRODUCTION

Primary Gastric Squamous Cell Carcinoma (GSCC), especially in late-stage, is a very rare pathological type with poor prognosis. We report a long duration of Complete Response (CR) of GSCC case with multiple metastases by an elaborate three-staged radical Concurrent Chemoradiotherapy (CCRT).

CASE PRESENTATION

A 36-year-old male suffered from weakness and melena, and then was diagnosed as primary GSCC with cT3N3M1, Stage IV. According to the characteristics of multiple lymph nodes metastases at supraclavicular, perigastric and pelvic regions, an individualized therapeutic strategy of three-staged radical CCRT was elaborately designed and cautiously performed even after the accidental massive hemorrhage of the upper digestive tract under the guidance of a multidisciplinary team. A long-term CR was achieved, with Progression Free Survival (PFS) and Overall Survival (OS) of 74 months by the last follow-up. The case with multiple metastases was radically treated as local advanced disease with complete success.

CONCLUSION

Patient with stage IV mGSCC who has achieved CR and unexpected long-term PFS and OS through CCRT due to precise judgement and well-designed individualized therapy. The immunomodulatory effect of radiation therapy on the tumor microenvironment may be a potential mechanism affecting treatment efficacy.

摘要

引言

原发性胃鳞状细胞癌(GSCC),尤其是晚期,是一种非常罕见的病理类型,预后较差。我们报告了一例通过精心设计的三阶段根治性同步放化疗(CCRT)实现长期完全缓解(CR)的GSCC多发转移病例。

病例介绍

一名36岁男性出现乏力和黑便,随后被诊断为原发性GSCC,cT3N3M1,IV期。根据锁骨上、胃周和盆腔区域多发淋巴结转移的特点,精心设计并谨慎实施了三阶段根治性CCRT个体化治疗策略,即使在多学科团队指导下上消化道意外大出血后仍继续进行。实现了长期CR,末次随访时无进展生存期(PFS)和总生存期(OS)均为74个月。该多发转移病例作为局部晚期疾病得到了根治性治疗并取得圆满成功。

结论

IV期mGSCC患者通过精确判断和精心设计的个体化治疗,经CCRT实现了CR以及意外的长期PFS和OS。放射治疗对肿瘤微环境的免疫调节作用可能是影响治疗效果的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0378/11565023/6a4f64bbf951/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验